At close: December 11 at 4:00:02 PM EST
Pre-Market: 8:22:15 AM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 14 | 11 | 14 | 14 |
| Avg. Estimate | -0.38 | -0.36 | -1.83 | -1.11 |
| Low Estimate | -0.6 | -0.54 | -2.07 | -1.86 |
| High Estimate | -0.2 | -0.23 | -1.64 | -0.36 |
| Year Ago EPS | -0.63 | -0.7 | -2.27 | -1.83 |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 13 | 8 | 14 | 14 |
| Avg. Estimate | 100.72M | 105.48M | 378.72M | 474.28M |
| Low Estimate | 99.84M | 95.8M | 377.82M | 412.42M |
| High Estimate | 103.62M | 110.81M | 381.63M | 498.8M |
| Year Ago Sales | 82.36M | 85.62M | 314.71M | 378.72M |
| Sales Growth (year/est) | 22.29% | 23.20% | 20.34% | 25.23% |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -0.55 | -0.57 | -0.51 | -0.48 |
| EPS Actual | -0.63 | -0.7 | -0.52 | -0.28 |
| Difference | -0.08 | -0.13 | -0.01 | 0.2 |
| Surprise % | -14.80% | -21.94% | -1.02% | 41.43% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.38 | -0.36 | -1.83 | -1.11 |
| 7 Days Ago | -0.38 | -0.36 | -1.82 | -1.09 |
| 30 Days Ago | -0.38 | -0.37 | -1.83 | -1.1 |
| 60 Days Ago | -0.42 | -0.4 | -2.11 | -1.37 |
| 90 Days Ago | -0.43 | -0.38 | -2.12 | -1.34 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 5 | 5 | 12 | 11 |
| Up Last 30 Days | 6 | 5 | 12 | 11 |
| Down Last 7 Days | 3 | -- | -- | 1 |
| Down Last 30 Days | 2 | -- | -- | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| GKOS | 39.69% | 48.20% | 19.59% | 39.23% |
| S&P 500 | 5.00% | 12.00% | 2.10% | 12.20% |
Upgrades & Downgrades
| Maintains | Wells Fargo: Overweight to Overweight | 12/11/2024 |
| Upgrade | Citigroup: Neutral to Buy | 12/11/2024 |
| Initiated | UBS: Buy | 12/6/2024 |
| Maintains | Stifel: Buy to Buy | 12/2/2024 |
| Downgrade | Morgan Stanley: Equal-Weight to Underweight | 12/2/2024 |
| Maintains | BTIG: Buy to Buy | 11/26/2024 |
Related Tickers
PEN Penumbra, Inc.
253.66
+4.70%
IRTC iRhythm Technologies, Inc.
89.93
+3.49%
RXST RxSight, Inc.
37.58
-4.06%
NARI Inari Medical, Inc.
58.21
+5.74%
SGHT Sight Sciences, Inc.
3.9000
-0.26%
QDEL QuidelOrtho Corporation
41.52
+7.84%
GMED Globus Medical, Inc.
82.94
+0.06%
BIO Bio-Rad Laboratories, Inc.
341.51
+0.48%
MASI Masimo Corporation
174.38
-0.15%
PODD Insulet Corporation
273.47
-0.48%